Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1140-1152
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1140
Table 1 Clinical and laboratory characteristics of study population at baseline, n (%)
Parametersn = 155
Age in yr, mean ± SD 49.0 ± 13.1
Male119 (77.0)
Etiology of cirrhosis
    Alcohol58 (37.4)
    Hepatitis B23 (14.8)
    Hepatitis C7 (4.5)
    NASH55 (35.4)
    Others14 (9.0)
Duration of RA in mo, median (range)5 (-48)
MELD scores, median (range)18.1 ± 8.6, 17(6-42)
Child-Pugh score, mean ± SD10.3 ± 1.8
Diabetes mellitus27 (17.4)
Hypertension12 (7.7)
Corrected body mass index in kg/m2, mean ± SD 20.25 ± 3.40
Obesity16 (10.3)
Chronic kidney disease9 (5.8)
Serum total bilirubin in mg/dL, median (range) 2.7 (0.3-28.5)
Serum AST, median (range) U/L60 (18-672)
Serum ALT, median (range) U/L32 (4-250)
Serum total protein, mean ± SD mg/dL5.8 ± 0.7
Serum albumin, mean ± SD mg/dL2.5 ± 0.5
Hypoproteinemia42 (27.0%)
INR, median (range)1.6 (0.4-6.7)
Serum sodium, mean ± SD meq/L130.0 ± 6.5
Serum potassium, mean ± SD meq/L4.07 ± 2.40
Serum urea in mg/dL, median (range)34 (12-191)
Creatinine in mg/dL, median (range)0.9 (0.3-3.7)
Hemoglobin in g/dL, mean ± SD 8.8 (4.2-65.0)
Total leukocyte count as /cmm, median (range)6130 (1750-34300)
Lymphocytopenia72 (46.5)
Esophageal varices
    None3 (1.9)
    Small grade92 (59.4)
    Large grade60 (38.0)
PHG
    Mild118 (76.0)
    Severe35 (22.6)
PHD31 (20.0)
Ascitic fluid analysis
    Cell count as /µL, median (range)100 (0-11200)
    Protein median in gm/dL, median (range) 1.1 (0.1-3.5)
    ADA in U/L, median (range) 10 (1-33)
    Triglycerides in mg/dL, median (range) 19.5 (0-224.0)
    SAAG, median (range)2.0 (1.2-4.0)